scispace - formally typeset
F

Frank B. Hu

Researcher at Harvard University

Publications -  1784
Citations -  295051

Frank B. Hu is an academic researcher from Harvard University. The author has contributed to research in topics: Type 2 diabetes & Diabetes mellitus. The author has an hindex of 250, co-authored 1675 publications receiving 253464 citations. Previous affiliations of Frank B. Hu include Southwest University & Brigham and Women's Hospital.

Papers
More filters
Journal ArticleDOI

A Low-Frequency Inactivating AKT2 Variant Enriched in the Finnish Population Is Associated With Fasting Insulin Levels and Type 2 Diabetes Risk

Alisa K. Manning, +312 more
- 01 Jul 2017 - 
TL;DR: The allelic spectrum for coding variants in AKT2 associated with disorders of glucose homeostasis is extended and bidirectional effects of variants within the pleckstrin homology domain ofAKT2 are demonstrated.
Journal ArticleDOI

Exogenous Hormone Use: Oral Contraceptives, Postmenopausal Hormone Therapy, and Health Outcomes in the Nurses' Health Study.

TL;DR: Findings from the NHS and a recent analysis of the Women's Health Initiative indicate that younger women who are closer to menopause onset have a more favorable risk-benefit profile than do older women from use of hormone therapy for relief of vasomotor symptoms.
Journal ArticleDOI

Higher Magnesium Intake Is Associated with Lower Fasting Glucose and Insulin, with No Evidence of Interaction with Select Genetic Loci, in a Meta-Analysis of 15 CHARGE Consortium Studies

Adela Hruby, +65 more
- 01 Mar 2013 - 
TL;DR: No magnesium-related SNP or interaction between any SNP and magnesium reached significance after correction for multiple testing, but nominal evidence of TRPM6 influence and magnesium interaction with select loci suggests that further investigation is warranted.
Journal ArticleDOI

Peroxisome Proliferator-Activated Receptor-γ2 P12A Polymorphism and Risk of Coronary Heart Disease in US Men and Women

TL;DR: These data do not support the hypothesis that the A12 allele is associated with a decreased risk of CHD, and the potential interaction between PPARG2 P12A, overweight, and increased CHD risk needs further evaluation.